What Is Fixed-Duration CLL Treatment and How Does It Work? - Everyday Health
What Is Fixed-Duration CLL Treatment and How Does It Work? Everyday Health
Leukemia News
Newly diagnosed acute myeloid leukemia in Fit patients: 2026 treatment algorithms - Nature
Newly diagnosed acute myeloid leukemia in Fit patients: 2026 treatment algorithms Nature
Delayed Diagnosis Masks Progression From SM to Mast Cell Leukemia - Hematology Advisor
Delayed Diagnosis Masks Progression From SM to Mast Cell Leukemia Hematology Advisor
Mapping Human Bone Marrow Yields New Tool, Insights on Blood Cancer - WCM Newsroom
Mapping Human Bone Marrow Yields New Tool, Insights on Blood Cancer WCM Newsroom
Older Age Is Independently Associated With Inferior Survival After PTCy-Based Unrelated Donor HSCT in Hematologic Malignancies - OncLive
Older Age Is Independently Associated With Inferior Survival After PTCy-Based Unrelated Donor HSCT in Hematologic Malignancies OncLive
Bispecific Therapies Expand Outpatient Treatment Options for Lymphoma and Leukemia - Pharmacy Times
Bispecific Therapies Expand Outpatient Treatment Options for Lymphoma and Leukemia Pharmacy Times
6-year-old cancer patient delivers live First Alert Forecast - First Alert 4
6-year-old cancer patient delivers live First Alert Forecast First Alert 4
Leukemia: What Primary Care Physicians Need to Know - American Academy Of Family Physicians | AAFP
Leukemia: What Primary Care Physicians Need to Know American Academy Of Family Physicians | AAFP
Study Reveals How Leukemia Cells Enter and Damage Lungs - NYU Langone Health
Study Reveals How Leukemia Cells Enter and Damage Lungs NYU Langone Health
All-Oral Treatment of Newly Diagnosed Acute Myeloid Leukemia - The New England Journal of Medicine
All-Oral Treatment of Newly Diagnosed Acute Myeloid Leukemia The New England Journal of Medicine
Nichole Denise Hogan's legacy lives on through community blood drives…Hogan died at age 13 from leukemia - New Pittsburgh Courier
Nichole Denise Hogan's legacy lives on through community blood drives…Hogan died at age 13 from leukemia New Pittsburgh Courier
Older Age Associated With Better Post-Transplant Survival in Newly Diagnosed AML - Clinical Oncology News
Older Age Associated With Better Post-Transplant Survival in Newly Diagnosed AML Clinical Oncology News
Acute Myeloid Leukemia: Valentina’s Story - Johns Hopkins Medicine
Acute Myeloid Leukemia: Valentina’s Story Johns Hopkins Medicine
Is the adult EBMT risk score valid and relevant for hematopoietic stem cell transplantation in children acute leukemia? - Nature
Is the adult EBMT risk score valid and relevant for hematopoietic stem cell transplantation in children acute leukemia? Nature
Local oxygen tension dictates hematopoietic cell growth and potency - Nature
Local oxygen tension dictates hematopoietic cell growth and potency Nature
Reduced-intensity reinduction for children and young persons with relapsed acute lymphoblastic leukemia - Nature
Reduced-intensity reinduction for children and young persons with relapsed acute lymphoblastic leukemia Nature
Copper depletion boosts CNS leukemia therapy by inhibiting nucleotide synthesis through impairment of mitochondrial complex IV activity - Nature
Copper depletion boosts CNS leukemia therapy by inhibiting nucleotide synthesis through impairment of mitochondrial complex IV activity Nature
Early inflammatory complications after haploidentical hematopoietic stem cell transplantation with post transplant cyclophosphamide for acute leukemia: a pediatric multicenter experience - Nature
Early inflammatory complications after haploidentical hematopoietic stem cell transplantation with post transplant cyclophosphamide for acute leukemia: a pediatric multicenter experience Nature
Repression of miR-29 via MYC leads to increased CD40 signaling in transformed follicular lymphoma | Leukemia - Nature
Repression of miR-29 via MYC leads to increased CD40 signaling in transformed follicular lymphoma | Leukemia Nature
The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D | Leukemia - Nature
The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D | Leukemia Nature
WVU Cancer Institute first in the world to treat ultra-rare leukemia using novel subcutaneous immunotherapy - WVU Medicine
WVU Cancer Institute first in the world to treat ultra-rare leukemia using novel subcutaneous immunotherapy WVU Medicine
Disparities Limit Equitable Access Across Europe to Pediatric CD19 CAR-T Therapy - Hematology Advisor
Disparities Limit Equitable Access Across Europe to Pediatric CD19 CAR-T Therapy Hematology Advisor
Understanding acute myeloid leukemia - Servier
Understanding acute myeloid leukemia Servier
A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia - Nature
A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia Nature
Immunophenotypic changes following menin inhibition in acute myeloid leukemia - Nature
Immunophenotypic changes following menin inhibition in acute myeloid leukemia Nature
Targeting BMP and TAZ/TEAD mechanotransduction pathways impairs acute myeloid leukemia chemoresistance - Nature
Targeting BMP and TAZ/TEAD mechanotransduction pathways impairs acute myeloid leukemia chemoresistance Nature
Advances in acute leukemia: new therapies and clinical trials - Penn Medicine
Advances in acute leukemia: new therapies and clinical trials Penn Medicine
Leukemia Breakthroughs Are Helping Patients Live Longer - City of Hope
Leukemia Breakthroughs Are Helping Patients Live Longer City of Hope
CD84 is a specific target for acute myeloid leukemia CAR-T cell therapy - Nature
CD84 is a specific target for acute myeloid leukemia CAR-T cell therapy Nature
Rare double-hit leukemia survivor: ‘Go straight to UT MD Anderson’ - UT MD Anderson
Rare double-hit leukemia survivor: ‘Go straight to UT MD Anderson’ UT MD Anderson
CRISPR-based platform pinpoints drivers of leukemia in patient cells - Penn Medicine
CRISPR-based platform pinpoints drivers of leukemia in patient cells Penn Medicine
Curing Most Leukemias on the Horizon: A 5-Decade MD Anderson Perspective on Leukemia Research - The ASCO Post
Curing Most Leukemias on the Horizon: A 5-Decade MD Anderson Perspective on Leukemia Research The ASCO Post
T cell prolymphocytic leukemia (TPLL): Symptoms, diagnosis and treatment - UT MD Anderson
T cell prolymphocytic leukemia (TPLL): Symptoms, diagnosis and treatment UT MD Anderson
Leading the Charge in Acute Myeloid Leukemia - University of Colorado Anschutz
Leading the Charge in Acute Myeloid Leukemia University of Colorado Anschutz
Chronic Myeloid Leukemia (CML): Background, Pathophysiology, Epidemiology - Medscape
Chronic Myeloid Leukemia (CML): Background, Pathophysiology, Epidemiology Medscape
The sialic shield of leukemia cells - Science | AAAS
The sialic shield of leukemia cells Science | AAAS
6-year-old cancer patient delivers First Alert Forecast - First Alert 4
6-year-old cancer patient delivers First Alert Forecast First Alert 4
Yale Study Identifies a New Class of Drug Targets for Aggressive Leukemia - Yale School of Medicine
Yale Study Identifies a New Class of Drug Targets for Aggressive Leukemia Yale School of Medicine
CRIP1 functions as an oncogene in acute myeloid leukemia by modulating glycolytic metabolic reprogramming - Nature
CRIP1 functions as an oncogene in acute myeloid leukemia by modulating glycolytic metabolic reprogramming Nature
Sylvester’s Researchers Lead Major Treatment Overhauls For Acute Myeloid Leukemia - University of Miami
Sylvester’s Researchers Lead Major Treatment Overhauls For Acute Myeloid Leukemia University of Miami